arginine has been researched along with arginyl-glycyl-aspartyl-serine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evanson, OA; Weiss, DJ; Wells, RE | 1 |
| Hirasawa, Y; Ito, K; Kato, Y; Kita, Y; Motoyama, Y; Nishio, M; Seki, J; Yamanaka, T | 1 |
2 other study(ies) available for arginine and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function.
Topics: Animals; Arginine; Aspartic Acid; Aspirin; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; Glycine; Horses; Oligopeptides; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex | 1997 |
In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Topics: Arginine; Aspirin; Benzamides; Dipeptides; Dose-Response Relationship, Drug; Humans; Oligopeptides; Peptide Fragments; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Serine Endopeptidases; Sulfonamides; Thiazoles; Thiazolidines; Thrombin | 1999 |